Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.

Weiner E, Ball MP, Buchholz AS, Gold JM, Evins AE, McMahon RP, Buchanan RW.

J Clin Psychiatry. 2012 Jan;73(1):95-102. doi: 10.4088/JCP.10m06143gre. Epub 2011 Apr 5.

PMID:
21535998
2.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
3.

A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR.

Biol Psychiatry. 2002 Jul 1;52(1):53-61.

PMID:
12079730
4.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
5.

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.

Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA.

J Clin Psychopharmacol. 2005 Jun;25(3):218-25.

PMID:
15876899
6.

The effect of bupropion sustained-release on cigarette craving after smoking cessation.

Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, Rigotti N, Sachs DP.

Clin Ther. 2002 Apr;24(4):540-51.

PMID:
12017399
7.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
8.

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD.

Ann Intern Med. 2001 Sep 18;135(6):423-33.

PMID:
11560455
9.

A comparison of sustained-release bupropion and placebo for smoking cessation.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

N Engl J Med. 1997 Oct 23;337(17):1195-202.

10.

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB.

N Engl J Med. 1999 Mar 4;340(9):685-91.

11.

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.

Clin Ther. 2001 May;23(5):744-52.

PMID:
11394732
12.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
13.

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

T√łnnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A, Sweet R, Townsend J.

J Intern Med. 2003 Aug;254(2):184-92.

14.

Extended treatment with bupropion SR for cigarette smoking cessation.

Killen JD, Fortmann SP, Murphy GM Jr, Hayward C, Arredondo C, Cromp D, Celio M, Abe L, Wang Y, Schatzberg AF.

J Consult Clin Psychol. 2006 Apr;74(2):286-94.

PMID:
16649873
15.

A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.

Fossati R, Apolone G, Negri E, Compagnoni A, La Vecchia C, Mangano S, Clivio L, Garattini S; General Practice Tobacco Cessation Investigators Group.

Arch Intern Med. 2007 Sep 10;167(16):1791-7.

PMID:
17846399
16.

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.

Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC.

Nicotine Tob Res. 2001 Nov;3(4):397-403.

PMID:
11694208
17.

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R.

Eur Heart J. 2003 May;24(10):946-55.

PMID:
12714026
18.

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients.

Reimherr FW, Cunningham LA, Batey SR, Johnston JA, Ascher JA.

Clin Ther. 1998 May-Jun;20(3):505-16.

PMID:
9663366
19.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group.

JAMA. 2006 Jul 5;296(1):47-55.

PMID:
16820546
20.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643

Supplemental Content

Support Center